Perceptive Advisors - PMV PHARMACEUTICALS INC ownership

PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 74 filers reported holding PMV PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.8%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of PMV PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$5,776,000
-35.8%
250,000
-17.1%
0.04%
-65.6%
Q3 2021$8,991,000
-82.4%
301,714
-79.8%
0.13%
-60.4%
Q2 2021$51,004,000
+107.7%
1,493,114
+100.0%
0.33%
+6.4%
Q1 2021$24,554,000
-54.9%
746,557
-15.7%
0.31%
-46.8%
Q4 2020$54,471,000
+153.4%
885,556
+46.2%
0.58%
+86.3%
Q3 2020$21,497,000605,5560.31%
Other shareholders
PMV PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 1,614,911$19,217,00059.24%
Euclidean Capital LLC 2,336,909$27,809,00025.82%
OUP Management Co., LLC 989,232$11,772,00018.33%
Nextech Invest Ltd. 1,385,807$16,491,0005.33%
Boxer Capital, LLC 3,163,795$37,649,0002.12%
PERSONAL CFO SOLUTIONS, LLC 550,342$6,549,0001.64%
Orbimed Advisors 6,563,077$78,101,0001.45%
RTW INVESTMENTS, LP 4,356,920$51,847,0001.20%
ACUTA CAPITAL PARTNERS, LLC 154,500$1,839,0000.79%
Monarch Partners Asset Management LLC 210,370$2,503,0000.75%
View complete list of PMV PHARMACEUTICALS INC shareholders